- Publications
- Influence
Share This Author
Erlotinib in previously treated non-small-cell lung cancer.
- F. Shepherd, J. Rodrigues Pereira, L. Seymour
- MedicineThe New England journal of medicine
- 14 July 2005
TLDR
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
- N. Hanna, F. Shepherd, P. Bunn
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 May 2004
TLDR
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- T. Mok, Yi-Long Wu, V. Papadimitrakopoulou
- Medicine, BiologyThe New England journal of medicine
- 16 February 2017
TLDR
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
- F. Shepherd, J. Dancey, J. Bérille
- MedicineJournal of clinical oncology : official journal…
- 10 May 2000
TLDR
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- K. Shedden, Jeremy MG Taylor, D. Beer
- BiologyNature Medicine
- 1 August 2008
TLDR
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- Edward S. Kim, V. Hirsh, J. Douillard
- Medicine, BiologyThe Lancet
- 22 November 2008
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
- J. Pignon, H. Tribodet, T. le Chevalier
- Medicine, BiologyJournal of clinical oncology : official journal…
- 20 July 2008
TLDR
Erlotinib in lung cancer - molecular and clinical predictors of outcome.
- M. Tsao, A. Sakurada, F. Shepherd
- Medicine, BiologyThe New England journal of medicine
- 14 July 2005
TLDR
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.
- T. Winton, R. Livingston, F. Shepherd
- MedicineThe New England journal of medicine
- 23 June 2005
TLDR
...
...